Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of December 2018. The report addresses a procedural matter regarding the Company's Annual Meeting of Shareholders originally scheduled for December 3, 2018.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes are reported. The only material event disclosed is the adjournment of the Annual Meeting of Shareholders due to a lack of quorum.
Guidance, Outlook, and Management Commentary
- Meeting Adjournment: The Annual Meeting held on December 3, 2018, was adjourned for one week.
- Reconvened Meeting: The meeting is rescheduled for Tuesday, December 10, 2018, at 12:00 p.m. (Israel time).
- Location: The reconvened meeting will take place at the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
Investor Verification Checklist
- Verify the outcome of the reconvened Annual Meeting scheduled for December 10, 2018.
- Confirm whether a quorum was achieved at the rescheduled meeting.
- Review subsequent filings for the official minutes and resolutions of the Annual Meeting.